37.3
[]. Brian D Hudson, et al. Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. FASEB J. 202 Dec;26(2):495-65.
[2]. C Jakobs, et al. 3-methyl-3-butenoic acid: an artefact in the urinary metabolic pattern of patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Clin Chim Acta. 90 Sep ;06():5-9.
[3]. J P D van Veldhoven, et al. Structure-activity relationships of trans-substituted-propenoic acid derivatives on the nicotinic acid receptor HCA2 (GPR09A). Bioorg Med Chem Lett. 20 May ;2(9):2736-9.
[4]. M Duran, et al. Organic acid excretion in a patient with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency: facts and artefacts. Clin Chim Acta. 97 Dec ;90(2):7-93.
[5]. Shogo Inamine, et al. Tritium-labelled isovaleryl-RYYRIK-NH2 as potential antagonist probe for ORL nociceptin receptor. Bioorg Med Chem. 204 Nov ;22(2):5902-9.
H35-H3-H335
P26-P264-P27-P20-P302+P352-P304+P340-P362+P364-P405-P50
326